Lorlatinib and Diabetic Ketoacidosis An Emerging Class Effect?
Patients on lorlatinib should be monitored for hyperglycemia, regardless of autoantibody status. This case raises concerns about potential metabolic toxicities of ALK inhibitors beyond what is currently recognized.
SPI1 Mutations Expand the Agammaglobulinemia Genetic Map
A novel de novo SPI1 mutation has been identified in a Chinese patient with agammaglobulinemia, adding another piece to the complex genetic puzzle of this primary immunodeficiency. This finding suggests that SPI1 should be considered in the diagnostic workup of patients with unexplained B-cell deficiency, particularly in cases where other known genetic causes have been excluded.
Improving Pediatric Drug Hypersensitivity Diagnosis
Drug hypersensitivity reactions in children pose unique diagnostic challenges. New guidelines emphasize structured assessments and updated diagnostic criteria to improve accuracy and patient safety.
Smoking and Cataracts: A Clearer Vision of Prevention
Smoking-related cataracts contribute significantly to global vision impairment, a burden potentially reduced with aggressive smoking cessation strategies. Primary care physicians are uniquely positioned to communicate the tangible risk of vision loss to motivate patients towards quitting.
Infections in Ichthyosis: A Call for Vigilance
Patients with ALOX12B-associated autosomal recessive congenital ichthyosis face significant infectious risks beyond the skin. Clinicians should adopt proactive surveillance and management strategies, including early broad-spectrum antibiotics, to mitigate life-threatening complications.
